JPS6183180A - Isochroman derivative and its preparation - Google Patents

Isochroman derivative and its preparation

Info

Publication number
JPS6183180A
JPS6183180A JP20539984A JP20539984A JPS6183180A JP S6183180 A JPS6183180 A JP S6183180A JP 20539984 A JP20539984 A JP 20539984A JP 20539984 A JP20539984 A JP 20539984A JP S6183180 A JPS6183180 A JP S6183180A
Authority
JP
Japan
Prior art keywords
formula
group
general formula
isochroman
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20539984A
Other languages
Japanese (ja)
Inventor
Masatoshi Yamato
大和 正利
Kuniko Hashigaki
橋垣 国子
Heitaro Tanaka
田中 兵太郎
Makoto Sato
誠 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MORISHITA SEIYAKU KK
Morishita Pharmaceuticals Co Ltd
Original Assignee
MORISHITA SEIYAKU KK
Morishita Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MORISHITA SEIYAKU KK, Morishita Pharmaceuticals Co Ltd filed Critical MORISHITA SEIYAKU KK
Priority to JP20539984A priority Critical patent/JPS6183180A/en
Publication of JPS6183180A publication Critical patent/JPS6183180A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound of formula I (R<1> is H, lower alkyl, aryl; R<2>, R<3> are H, alkyl, aryl, aralkyl). EXAMPLE:1-[2-(N-benzylamino)propyl]isochroman. USE:Since it has powerful inhibition of gastric juice excretion, the compound is very effective in treatment or prevention for hyperacid, gastric ulcer and duodenal ulcer. PREPARATION:The reaction of 1-ethoxyisochroman with a carbonyl compound is effected, the product of formula II is allowed to react with an amine of R<3>NH2, then the resultant Schiff base of formula III is reduced to give of formula I when R<2> is H. Or the compound of formula II is reduced, then halogenated and the product of formula IV (X is halogen) is allowed to react with an amine of formula V to give the compound of formula I.

Description

【発明の詳細な説明】 本発明は、一般式 (式中、R’ は水素原子、低級アルキル基またはアリ
ール基を、RzおよびRコは、同一または相異なって、
水素原子、アル・キル基、アリール基またはアラルキル
基を表す)で示されるイソクロマン誘導体およびその製
造法に関する6前記一般式(I]において、R1で表さ
れる低級アルキル基としては、たとえばメチル基、エチ
ルJJ、n−プロピル基などが挙げられ、アリール基と
しては、たとばフェニル基、ナフチル基などが挙げられ
、これらのアリール基は、フッ素、塩、累、臭素、三フ
ッ化メチル、メチル、エチル、メトキシ、ニドキシ、n
−プロポキン、ニトロなどの置?!13を1〜2個有し
ていてもよい。
DETAILED DESCRIPTION OF THE INVENTION The present invention is based on the general formula (wherein R' is a hydrogen atom, a lower alkyl group or an aryl group, and Rz and R are the same or different,
6 Relating to isochroman derivatives represented by hydrogen atoms, alkyl groups, aryl groups, or aralkyl groups and their production methods In the above general formula (I), the lower alkyl group represented by R1 is, for example, a methyl group, Examples of the aryl group include ethyl JJ, n-propyl group, etc.; examples of the aryl group include phenyl group, naphthyl group, etc.; ethyl, methoxy, nidoxy, n
- Placement of propoquine, nitro, etc.? ! It may have one or two 13.

また、R1およびR3で表されるアルキル基としては、
たとえばメチルからn−ヘプチルまでの直鎖状アルキル
基やインプロピル、イソブチル、5ec−ブチル、ta
rt−ブチルなどの分岐状アルキル基が挙げられ、アリ
ール基としては、前記例示と同じ意義のフェニル基、ナ
フチル基などが挙げられ、アラルキル基としては、ベン
ジル凸、フェネチル基などが挙げられる。
In addition, the alkyl group represented by R1 and R3 is
For example, linear alkyl groups from methyl to n-heptyl, inpropyl, isobutyl, 5ec-butyl, ta
Examples include branched alkyl groups such as rt-butyl; examples of the aryl group include phenyl groups and naphthyl groups having the same meanings as the above-mentioned examples; examples of the aralkyl groups include benzyl convex and phenethyl groups.

前記一般式(1)で示される本発明のイソクロマン誘導
体は新規化合物で、消化性a瘍の治療薬ないし予防薬と
して使用され得る。すなわち、ラット、マウスなどの動
物で胃酸分泌を強力に抑制するとともに、アスピリン、
ストレス、ソエイなどの実験的a瘍の発生を抑制し、そ
の作用は持続的であり、また、毒性、1耐性についても
特に問題はなく、したがって胃酸過多、胃がL−二指腸
漬Iffの治療または予防に極めて有効である。
The isochroman derivative of the present invention represented by the general formula (1) is a new compound and can be used as a therapeutic or preventive agent for peptic ulcers. In other words, it strongly suppresses gastric acid secretion in animals such as rats and mice, and aspirin,
It suppresses the occurrence of experimental ulcers such as stress and soei, and its action is continuous, and there are no particular problems with toxicity and tolerance. Extremely effective for treatment or prevention.

さらに、同作用を有する池の化合物を作るための中間体
としても重要である。
Furthermore, it is important as an intermediate for making compounds with the same effect.

本発明の化合物〔1〕は、種々の方法で製造され得るが
、本発明者らが鋭意研究した結果完成した工業的に有利
な製造法は塚下の如くである。
Compound [1] of the present invention can be produced by various methods, but the industrially advantageous production method completed by the present inventors as a result of intensive research is as described by Tsukashita.

まず、前記一般式(1)においてR1が水素原子の化合
物は、下記反応式で示す方法により製造[11〕[lV
] (式中、R1およびR)は前記と同し)すなわち、l−
エトキノイソクロマンと対応するカルボニル化合物とを
大和らの方法(T、 Ishikawa、 M、Yam
ato、 Chem、Pharm、Bull、、30.
1594(1982)〕に従って反応させることにより
得られる化合物〔II〕 と、アミン類(III 3を
反応させてノノフ塩i(Iν〕を得、これを1五元する
ことにより目的化合物(la’lが得られる。
First, a compound in which R1 is a hydrogen atom in the general formula (1) is produced by the method shown in the following reaction formula [11] [lV
] (In the formula, R1 and R are the same as above) That is, l-
Ethoquinoisochroman and the corresponding carbonyl compound were prepared by the method of Yamato et al.
ato, Chem, Pharm, Bull, 30.
1594 (1982)] and the amines (III 3) to obtain the nonov salt i (Iν), and by converting it into 15 elements, the target compound (la'l is obtained.

化合物[I+] とアミンji [111] との反応
は、過剰の該アミン類を用いて無溶媒下またはジエチル
エーテル、クロロホルム、ヘンゼンなトノ不活性溶媒中
、室温ないし加温下で行う、化合物(IV)の還元は、
エーテル類の溶媒中、水素化ホウ素ナトリウム、水素化
アルミニウムリチウムあるいはシアノ水素化ホウ素ナト
リウムのような還元剤を用い、室温ないし加温下で行え
ばよい、なお、先の反応で溶媒にエーテル類を用いた場
合は、化合物(IV)を単離することなく続いて還元反
応を行うことができる。
The reaction between compound [I+] and amine ji [111] is carried out using an excess of the amine in the absence of a solvent or in an inert solvent such as diethyl ether, chloroform, or hexane at room temperature or under heating. The return of IV) is
This can be carried out in an ether solvent using a reducing agent such as sodium borohydride, lithium aluminum hydride or sodium cyanoborohydride at room temperature or under heating. When used, the reduction reaction can be carried out subsequently without isolating compound (IV).

また、本発明の化合物〔1〕は、次式によって有利に製
造できる。
Moreover, the compound [1] of the present invention can be advantageously produced by the following formula.

(式中、Xはハロゲン原子を表し、R1,R1およびR
3は前記一般式〔1〕と同し)すなわち、目的化合物(
13は、前記化合物(I+]を還元し、ついでハロゲン
化して得られる化合物(V)とアミン類1:VI] と
を反応させることにより得られる。
(In the formula, X represents a halogen atom, R1, R1 and R
3 is the same as the above general formula [1]), that is, the target compound (
13 can be obtained by reducing the compound (I+) and then reacting the compound (V) obtained by halogenation with the amines 1:VI].

この反応は、無溶媒下またはエーテル類、クロロホルム
、アセトニトリル、ジメチルホルムアミドのような不活
性溶媒中、通常、炭酸カリウムのような脱ハロゲン化水
素剤の存在下、加温ないし加弘還流して行う。
This reaction is carried out without a solvent or in an inert solvent such as ethers, chloroform, acetonitrile, or dimethylformamide, usually in the presence of a dehydrohalogenating agent such as potassium carbonate, and by heating or refluxing. .

さらに、前記一般式(+)において、R’が水素原子の
場合は、下記の方法で製造してもよい。
Furthermore, in the general formula (+), when R' is a hydrogen atom, it may be produced by the following method.

Mll              [yI則(式中、
X、R”およびR3は前記と同じ)すなわち、前記大和
らの方法に従って1−エトキシイソクロマンとマロン酸
ジエチルを反応させ、続いて加水分解、脱炭酸、ハロゲ
ン化して得られる化合物(Mll )と、アミンr(I
 Cν■〕とを反応させ化合物(Vlll]を得、これ
を還元して目的化合物(Ib)が得られる。
Mll [yI rule (wherein,
(X, R'' and R3 are the same as above) That is, a compound (Mll) obtained by reacting 1-ethoxyisochroman and diethyl malonate according to the method of Yamato et al., followed by hydrolysis, decarboxylation, and halogenation. , amine r(I
Cv■] to obtain a compound (Vlll), which is reduced to obtain the target compound (Ib).

化合物(Vl’l )とアミ7類(Vllとの反応は、
通常、前述のような不活性溶媒中、トリエチルアミンあ
るいはピリジンのような脱ハロゲン化水素剤の存在下、
室温ないし加温下で行う。また、化合物(V[I+]の
還元は前記の方法と同様にして行うことができる。
The reaction between compound (Vl'l) and amide 7 (Vll) is
Usually in an inert solvent as described above, in the presence of a dehydrohalogenating agent such as triethylamine or pyridine,
Perform at room temperature or under heating. Further, the reduction of the compound (V[I+] can be carried out in the same manner as the above-mentioned method.

以上のようにして得られた目的化合物(11は。The target compound (11) obtained as above.

たとえば再結晶法、カラムク1コマトゲラフイーなどの
公知の手段を用いて容易に’ii i!+1口n製でき
る。
For example, the 'ii i! +1 unit can be manufactured.

また、本発明の化合物(11は公知の方法に従って、た
とえば塩酸塩、臭化水素酸塩、硫酸塩などの無機酸塩、
あるいは酢酸塩、マレイン酸塩、酒石酸塩、り−)ルエ
ンスルホン酸塩、メタンスルホン酸塩などの有a酸塩や
四級アンモニウム塩とすることができる。
In addition, the compound of the present invention (11 can be prepared according to a known method, for example, an inorganic acid salt such as a hydrochloride, a hydrobromide, a sulfate, etc.)
Alternatively, it can be an a-acid salt or a quaternary ammonium salt such as an acetate, a maleate, a tartrate, a lyluenesulfonate, or a methanesulfonate.

以下、実施例を挙げて本発明を5“I′:述する。The present invention will be described below with reference to Examples.

実施例1 (1)1−エトキノイソクロマン30gと無水アセトン
30gの混合物に47%三フッ化ホウ素・ジエチルニー
テレート6+nlを加え、このものを窒素気流中40℃
で3時間撹拌する。反応物をエーテルにて抽出し、エー
テル層を10%炭酸水素カリウムおよび水で洗浄後、乾
燥し、bp 11B−120℃(0,05BmHg)の
(イソクロマン−1−イル)アセトンを粘稠な油状物と
して22.9g  (61%)得る。
Example 1 (1) 6+nl of 47% boron trifluoride diethyl nitrate was added to a mixture of 30 g of 1-ethoquinoisochromane and 30 g of anhydrous acetone, and the mixture was heated at 40°C in a nitrogen stream.
Stir for 3 hours. The reaction product was extracted with ether, the ether layer was washed with 10% potassium bicarbonate and water, dried, and (isochroman-1-yl)acetone at bp 11B-120°C (0.05BmHg) was extracted into a viscous oil. 22.9 g (61%) of solids were obtained.

IRν=賎’cff−’: 1715 (C・0)N 
M R(CC1,)δ: 2.16(3H,s、C0C
IIz)、2.97(2H,d。
IRν=賎'cff-': 1715 (C・0)N
M R (CC1,) δ: 2.16 (3H,s, C0C
IIz), 2.97 (2H, d.

JJIIz、CIIzCOCTo)、 33−5O−4
−32(4N1+3・Ilz and 4−Hz) 5
.18(lH,t、J−6Hz、1−H)、 7.13
(4H,s、Ar−H)(2)(イソクロマン−1−イ
ル)アセトン4gとヘンシジルアミン3.4gをエーテ
ル中、室温で4時間攪拌した後、水素化ホウ素ナトリウ
ム1gと無水メタノール60m1を加え、さらに室温で
3時間撹拌する。大部分の溶媒を留去し、残渣を酢酸エ
チルにて抽出する。酢酸エチル層を5%塩酸にて抽出し
、その塩酸層を5%水酸化カリウム?8液でアルカリ性
にしたのち、酢酸エチルで抽出する。
JJIIz, CIIzCOCTo), 33-5O-4
-32 (4N1+3・Ilz and 4-Hz) 5
.. 18 (lH, t, J-6Hz, 1-H), 7.13
(4H,s,Ar-H) (2) After stirring 4 g of (isochroman-1-yl)acetone and 3.4 g of hensidylamine in ether at room temperature for 4 hours, 1 g of sodium borohydride and 60 ml of anhydrous methanol were added. and further stirred at room temperature for 3 hours. Most of the solvent is distilled off, and the residue is extracted with ethyl acetate. The ethyl acetate layer was extracted with 5% hydrochloric acid, and the hydrochloric acid layer was extracted with 5% potassium hydroxide. After making alkaline with liquid 8, extract with ethyl acetate.

酢酸エチル層を水洗、乾燥後、t8ゲIを留去する。After washing the ethyl acetate layer with water and drying, t8ge I was distilled off.

残渣をアルミナカラムクロマトグラフィーに付し、酢酸
エチルと石油エーテルの混液にて溶出し、■−(2−(
N−ベンジルアミノ)プロピルコイソクロマンを2.8
g(47χ)1)る。
The residue was subjected to alumina column chromatography and eluted with a mixture of ethyl acetate and petroleum ether to give ■-(2-(
N-benzylamino)propylcoisochroman 2.8
g(47χ)1).

IRシュ七1C閘−’: 3340 (N11)。IR Shu 7 1C Lock-’: 3340 (N11).

N M R(CG++)δ: 1.08,1.13(b
oth 3N、d、each J=6Hz、>CIIC
Hs)、  1.15−2.18(311,m、Cl1
tCH<)、2.56−3.30(311,m、>CH
Ct13 and 4−Ht)、 3.40−4.28
(2H。
NMR(CG++)δ: 1.08, 1.13(b
oth 3N, d, each J=6Hz, > CIIC
Hs), 1.15-2.18 (311, m, Cl1
tCH<), 2.56-3.30 (311, m, >CH
Ct13 and 4-Ht), 3.40-4.28
(2H.

m、3−)1t)、 3.73(211,s、N11C
lh)、 4.59 5.09(IH,剛。
m, 3-)1t), 3.73(211,s, N11C
lh), 4.59 5.09 (IH, Tsuyoshi.

14)、7.05(4H,s、Ar−11)、 7.2
5(5H5s、C&+Is)。
14), 7.05 (4H,s, Ar-11), 7.2
5 (5H5s, C&+Is).

M S vx/z: 28BM−)。M S vx/z: 28BM-).

このものを常法に従って塩酸塩となし、mp 175−
177℃(dec、)の結晶をi)る。
This product was converted into hydrochloride according to a conventional method, and mp 175-
i) Crystals at 177°C (dec,).

実施例2〜7 実施例1の方法と同様な方法で第1表に示す化合物をい
ずれも油状物として得た。
Examples 2 to 7 All of the compounds shown in Table 1 were obtained as oils in the same manner as in Example 1.

実施例8 (1)l−エトキンイソクロマン30gとアセトフェノ
ン25gの混合物に479A三フツ化ホウ素・ジエチル
ニーテレ−)?+alを加え、窒素気流中、40℃で2
時間攪拌する0反応物をエーテルにて抽出し、エーテル
層を5%炭酸水素カリウム水溶液および水で洗浄後、乾
燥し、溶媒を留去する。残渣を減圧蒸溜し、bp 16
0−163℃(0,03mmHg)のα−(イソクロマ
ン−1−イル)アセトフェノンt−32g(78%)得
る。 Mp  43−45℃。
Example 8 (1) 479A boron trifluoride/diethylnitere) in a mixture of 30 g of l-ethquine isochromane and 25 g of acetophenone? +al was added and heated at 40°C in a nitrogen stream for 2 hours.
The reaction mixture was stirred for an hour and the reaction mixture was extracted with ether. The ether layer was washed with a 5% aqueous potassium bicarbonate solution and water, dried, and the solvent was distilled off. The residue was distilled under reduced pressure, bp 16
Obtain 32 g (78%) of α-(isochroman-1-yl)acetophenone t-at 0-163°C (0.03 mmHg). Mp 43-45°C.

I Rv品SH’cva−’: 1680 (CJ) 
I Rv product SH'cva-': 1680 (CJ)
.

N M R(CCIa)δ: 2.46−3.00(2
11,閘、4’−1h)、 3.16−3.46(2H
,a、cHzcO)、 3.51−4.43(211,
+*、3’−L)。
NMR(CCIa)δ: 2.46-3.00(2
11, lock, 4'-1h), 3.16-3.46 (2H
, a, cHzcO), 3.51-4.43 (211,
+*, 3'-L).

5.41(III、t、J−6Hz、l’−H)、  
7.15(4H,s、八r−H)、  7.26−7.
68(311,m、311.4−II、and 511
)、 7.79 8.18(211,m。
5.41 (III, t, J-6Hz, l'-H),
7.15 (4H, s, 8r-H), 7.26-7.
68 (311, m, 311.4-II, and 511
), 7.79 8.18 (211, m.

2−Hand 6−If)。2-Hand 6-If).

(2)α−(イソクロマン−1−イル)アセトフェノン
logとフェネチルアミン7.2gを無水エーテル中室
温で4時間攪拌後、溶媒を留去する。残渣に無水ヘンゼ
ンを加えて、共沸蒸溜によって生成した水を留去した後
、このものの無水エーテルc8液を水素化リチウムアル
ミニウム3.5gを無水エーテルに懸濁させたもののな
かに、水冷下溝下する。
(2) After stirring log α-(isochroman-1-yl)acetophenone and 7.2 g of phenethylamine in anhydrous ether at room temperature for 4 hours, the solvent was distilled off. After adding anhydrous Hensen to the residue and distilling off the water produced by azeotropic distillation, this anhydrous ether C8 liquid was poured into a suspension of 3.5 g of lithium aluminum hydride in anhydrous ether under water cooling. do.

その後、5時間加熱還流させた後、水を加え、酢酸エチ
ルにて抽出する。酢酸エチル層を5%炭酸水素カリウム
水溶液および水で洗浄し、乾燥後、溶媒を留去する。残
渣をアルミナカラムクロマトグラフィーに付し、石油エ
ーテル・酢酸エチルにて溶出し、1−(1−(N−フェ
ネチルアミノ)フェネチルコイソクロマンを粘稠な油状
物として3.2g (17%)得る。
After that, the mixture was heated under reflux for 5 hours, water was added, and the mixture was extracted with ethyl acetate. The ethyl acetate layer is washed with a 5% aqueous potassium hydrogen carbonate solution and water, and after drying, the solvent is distilled off. The residue was subjected to alumina column chromatography and eluted with petroleum ether/ethyl acetate to obtain 3.2 g (17%) of 1-(1-(N-phenethylamino)phenethylcoisochroman) as a viscous oil.

I Ry殻:’cm−’: 3350 (NH)。I Ry shell: 'cm-': 3350 (NH).

N M R(CC1,)δ: 1.93(Ill、s、
N11)、 1.89−2.29(28゜+n、CII
tCH<)、  2.54 −3.30(611,m、
NIICIIz(:1IzPh  and  4−Hz
)、 3−46 −4.27(3M、−、>CllPh
  and  3−Ib)14.50(0,5H,t、
J−61Lz、1−H)、 4.97(0,511,t
、J=6Hz、1−H)。
NMR(CC1,)δ: 1.93(Ill,s,
N11), 1.89-2.29 (28°+n, CII
tCH<), 2.54 -3.30 (611, m,
NIICIIz(:1IzPh and 4-Hz
), 3-46 -4.27 (3M, -, >CllPh
and 3-Ib) 14.50 (0,5H,t,
J-61Lz, 1-H), 4.97 (0,511,t
, J=6Hz, 1-H).

7.18(48,s、Ar−H)、 7.24−7.6
4(10H,m、C,Hs X 2)。
7.18 (48,s, Ar-H), 7.24-7.6
4 (10H, m, C, Hs x 2).

MS mHz: 357(M”)− このものを常法に従って塩酸塩となし、mp +74−
176℃(dec、)の結晶を1)る。
MS mHz: 357 (M”)- This product was converted into hydrochloride according to a conventional method, and mp +74-
1) Gather the crystals at 176°C (dec).

実施例9 α−(イソクロマン−■−イル)アセトフェノン4gと
メチルアミン5.4gを60m1のメタノールに溶かし
、このものにシアノ水素化ホウ素ナトリウムをIg加え
、室温で7時間攪拌する。大部分の溶媒を減圧下に留去
し、残渣を酢酸エチルにて抽出する。酢酸エチル層を5
%塩酸にて抽出し、その塩酸層を5%水酸化ナトリウム
溶液でアルカリ性となし、酢酸エチルにて抽出する。酢
酸エチル層を水洗乾燥後、溶媒を留去する。残渣をアル
ミナカラムクロマトグラフィーに付し、石油エーテル・
酢酸エチルにて溶出し、粘稠な油状物として1−(1−
(N−メチルアミノ)フェネチルコイソクロマンを2.
2g(53χ)得る。
Example 9 4 g of α-(isochroman-■-yl)acetophenone and 5.4 g of methylamine were dissolved in 60 ml of methanol, and Ig of sodium cyanoborohydride was added thereto, followed by stirring at room temperature for 7 hours. Most of the solvent is distilled off under reduced pressure, and the residue is extracted with ethyl acetate. 5 ethyl acetate layer
% hydrochloric acid, the hydrochloric acid layer is made alkaline with 5% sodium hydroxide solution, and extracted with ethyl acetate. After washing the ethyl acetate layer with water and drying, the solvent was distilled off. The residue was subjected to alumina column chromatography, and petroleum ether
It was eluted with ethyl acetate and 1-(1-
(N-methylamino)phenethylcoisochroman 2.
Obtain 2g (53χ).

l  RvQ::Lcm−’:  3360  (lL
H)−NMR(CC1,)δ: 1.70(III、s
、NH)、 1.84−2.09(2hm、CToCH
<)、 2−22(3H1s、NCIh)+ 2.51
−2.96(2H,m。
l RvQ::Lcm-': 3360 (lL
H)-NMR (CC1,) δ: 1.70 (III, s
, NH), 1.84-2.09 (2hm, CToCH
<), 2-22 (3H1s, NCIh) + 2.51
-2.96 (2H, m.

4−1h)l 3.56   4.18(311,m、
CHlCII<  and  3−Hz)。
4-1h) l 3.56 4.18 (311, m,
CHlCII < and 3-Hz).

4.46(0,71+、t、J=6Hz、1−1f)+
 4.98(0,3H,t、J=6Hz、1−H)、 
7.18(4H,s、Ar−H)、 7.04(411
,s、Ar−)1)、 7.18−7.65(5rr、
m、Ar−H)。
4.46 (0,71+, t, J=6Hz, 1-1f)+
4.98 (0,3H, t, J=6Hz, 1-H),
7.18 (4H,s, Ar-H), 7.04 (411
,s,Ar-)1), 7.18-7.65(5rr,
m, Ar-H).

M S  mHz:  267(M’)。M S mHz: 267 (M').

実施例IO 実施例9と同様な方法で1(1−(N−ブチルアミノ)
フェネチル〕イソクロマンを製造した。
Example IO In a similar manner to Example 9, 1(1-(N-butylamino)
phenethyl isochroman was produced.

I Rv−3’cm−’: 3360 (Nll)、N
 M R(CCL)δ: 0.80 0.98(311
,m、C1h)、1.191.54(4■、m、CII
zCIltCIIi)、 1.74(111,s、N1
1)、 1.94−2.27(2H,l、3−Hり、 
4.45(0,711,t、J=711z、I−H)、
4.96(0,31(、t、J=7Hz、1−It)、
6.94.6.99(both  4H,s、s、Ar
−II)、 7.18−7.58(5H,++、Ar−
11)。
I Rv-3'cm-': 3360 (Nll), N
M R (CCL) δ: 0.80 0.98 (311
, m, C1h), 1.191.54 (4■, m, CII
zCIltCIIi), 1.74 (111,s, N1
1), 1.94-2.27 (2H, l, 3-Hri,
4.45 (0,711,t, J=711z, I-H),
4.96(0,31(,t,J=7Hz,1-It),
6.94.6.99 (both 4H, s, s, Ar
-II), 7.18-7.58 (5H, ++, Ar-
11).

M S mHz: 309(M ’)。M S mHz: 309 (M').

このものを常法に従って塩酸塩となし、mp 170−
175℃(dec、)の結晶を得る。
This product was converted into hydrochloride according to a conventional method, and mp 170-
Obtain crystals at 175°C (dec).

実施例11 (1)(イソクロマン−1−イル)アセトン6gをメタ
ノールにン容かし、水素化ホウ素ナトリウム1gを加え
、室温で2時間1毘拝する6大部分のメタノールを減圧
下に留去し、残渣を酢酸エチルにて4th出する。酢酸
エチル層を水洗乾燥後、溶媒を留去し、残渣を減圧蒸溜
し、bp too−105℃(0,03−−Hg)の1
−(イソクロマン−1−イル)−2−プロパツールを5
.4g(87χ)得る6I Rv芯上cm−’: 34
40 (011)。
Example 11 (1) Add 6 g of (isochroman-1-yl)acetone to methanol, add 1 g of sodium borohydride, and stir at room temperature for 2 hours. 6 Most of the methanol is distilled off under reduced pressure. The residue was extracted with ethyl acetate for 4 times. After washing the ethyl acetate layer with water and drying, the solvent was distilled off, and the residue was distilled under reduced pressure.
-(isochroman-1-yl)-2-propatool 5
.. 4g (87χ) obtained 6I Rv cm-' on core: 34
40 (011).

NMR(CC1,ン δ :  1.13,1.16(
both  317.d、each  J=6Hz、C
)Is)、 1.25−2.07(2H,m、CHzC
H<)、 2.60−3.60(:llI、+i、44
z)、 3.33−3.59(IH,br、OH)、 
3.62−3.89(IH,m、>C11CHx)、3
.92−4.32(2H,m、3−1h)、4.73−
5.14(IH,m、1−14)、 7.10(41,
s、Ar−11)。
NMR (CC1, n δ: 1.13, 1.16 (
Both 317. d, each J=6Hz, C
) Is), 1.25-2.07 (2H, m, HzC
H<), 2.60-3.60 (:llI, +i, 44
z), 3.33-3.59 (IH, br, OH),
3.62-3.89 (IH, m, >C11CHx), 3
.. 92-4.32 (2H, m, 3-1h), 4.73-
5.14 (IH, m, 1-14), 7.10 (41,
s, Ar-11).

M S Jz: 192(M”)。M S Jz: 192 (M”).

(2)1〜(イソクロマン−1−イル)−2−プロパツ
ール1.5 gとトリフェニルホスフィ/3.3g、お
よび無水ジメチルホルムアミド40m1に溶かし、この
ものに臭素を水冷下で、臭素の色が消失するまで滴下し
、さらに室温で1時間撹拌する0反応液を酢酸エチルニ
テ抽出し、酢酸エチル層を水洗乾燥後、溶媒を留去する
。残渣をノリカゲル力ラムクロマトグラフィーに付し、
石油エーテル・酢酸エチルにて溶出し、油状物の1−(
イソクロマン−1−イルシン−2−プロピルブロマイド
(69χ)を得る。
(2) Dissolve 1.5 g of 1-(isochroman-1-yl)-2-propatol in 3.3 g of triphenylphosphine and 40 ml of anhydrous dimethylformamide, and add bromine to this solution under water cooling. The mixture was added dropwise until the color disappeared, and the mixture was further stirred at room temperature for 1 hour. The reaction solution was extracted with ethyl acetate, and the ethyl acetate layer was washed with water and dried, and then the solvent was distilled off. The residue was subjected to Norica gel column chromatography,
Eluted with petroleum ether/ethyl acetate, an oily substance 1-(
Isochroman-1-ylcine-2-propyl bromide (69χ) is obtained.

N M R(CC14)δ:  1.75.1.81(
hotl+ 311.d、each  J=611z、
CH3ン、   1.96−2.44(211,s、C
11IC1l<)、  2.65−3.04(2H,+
w、4−Ht)、  3.65−4.16(211,m
、3−11t)、  4.745.14(111,11
,1−11)、  7.14(411,s、^r−If
)。
NMR(CC14)δ: 1.75.1.81(
hotl+ 311. d, each J=611z,
CH3, 1.96-2.44 (211,s, C
11IC1l<), 2.65-3.04(2H, +
w, 4-Ht), 3.65-4.16 (211, m
, 3-11t), 4.745.14 (111,11
, 1-11), 7.14 (411,s, ^r-If
).

−H)、  7.18−7.58(511,m、八r−
1f)。
-H), 7.18-7.58 (511,m, 8r-
1f).

MS mHz: 254(Mつ。MS mHz: 254 (M).

(3) 1− (イソクロマン−1−イル)−2−プロ
ピルブロマイド4.3g%ter t−ブチルアミン7
.4g、!哄水炭酸カリウム3.5g、および乾燥ツメ
チルホルムアミド20m lの混合物を60℃で40時
間N拌する。
(3) 1-(isochroman-1-yl)-2-propyl bromide 4.3g% tert-butylamine 7
.. 4g! A mixture of 3.5 g of potassium carbonate and 20 ml of dry trimethylformamide was stirred at 60° C. for 40 hours.

反応液を酢酸エチルにて抽出し、酢酸エチル層を5%塩
酸にて抽出、その塩酸層を20χ水酸化ナトリウム溶液
でアルカリ性となし酢酸エチルにて抽出する。酢酸エチ
ル層を水洗乾燥後、溶媒を留去する。残渣をアルミナカ
ラムクロマトグラフィーに付し、酢酸エチル・石油エー
テルにて溶出し、1− (2−(N−tert−ブチル
アミノ)プロピルイソクロマンを1.5g(3(iχ)
得る。
The reaction solution was extracted with ethyl acetate, the ethyl acetate layer was extracted with 5% hydrochloric acid, the hydrochloric acid layer was made alkaline with 20x sodium hydroxide solution, and extracted with ethyl acetate. After washing the ethyl acetate layer with water and drying, the solvent was distilled off. The residue was subjected to alumina column chromatography, eluted with ethyl acetate/petroleum ether, and 1.5 g (3(iχ)
obtain.

l  Rv ””cm−’:  3350  (Nll
)。
l Rv ””cm-': 3350 (Nll
).

NM R(CC1m)δ:  0.71(IH,s、N
H)、1.0H911,s、C<CI(り3)、 1.
03.1.07(boLh 3H,d、each J=
611z、>CHCll3)。
NMR(CC1m)δ: 0.71(IH,s,N
H), 1.0H911,s, C<CI(ri3), 1.
03.1.07 (boLh 3H, d, each J=
611z,>CHCll3).

1.69−1.94(2H,m、CHzCH<)、  
2.58−3.28(31(、m、C:H−C1l、 
and 4−11z)、  3.61−4.26(2L
顧、3−tit)、  4.52−4.84(LH,艶
、1−H)、  7.04(411,m、八r−)1)
1.69-1.94 (2H, m, CHzCH<),
2.58-3.28(31(,m,C:H-C1l,
and 4-11z), 3.61-4.26 (2L
Gu, 3-tit), 4.52-4.84 (LH, gloss, 1-H), 7.04 (411, m, 8 r-) 1)
.

MS  mHz:  247(M′)。MS mHz: 247 (M').

実施例12 1−(2−(N−ベンジルアミノ)プロピルコイソクロ
マン2gとホルマリン3mlとをア七トニトリル溶かし
、このものにシアノ水素化ホウ素ナトリウム0.75g
を水冷下加える。さらに、酢酸を反応液が中性になるま
で加え、室温で1時間攪拌する。tJ&圧下溶媒を留去
し、残渣を水酸化カリウムにてアルカリ性とした後、酢
酸エチルにて抽出する。酢酸エチル層を水洗乾燥後、溶
媒を留去する。残渣をアルミナカラムクロマトグラフィ
ーに付し、酢酸エチル・石油エーテルにて溶出し、1−
 (2−(N−ベンジル−N−メチルアミン)プロピル
コイソクロマンを粘稠な油状物として1.3g(63χ
)得る。
Example 12 2 g of 1-(2-(N-benzylamino)propylcoisochroman and 3 ml of formalin are dissolved in a7tonitrile, and 0.75 g of sodium cyanoborohydride is dissolved in this solution.
Add under water cooling. Furthermore, acetic acid was added until the reaction solution became neutral, and the mixture was stirred at room temperature for 1 hour. The solvent was distilled off under tJ&pressure, the residue was made alkaline with potassium hydroxide, and then extracted with ethyl acetate. After washing the ethyl acetate layer with water and drying, the solvent was distilled off. The residue was subjected to alumina column chromatography, eluted with ethyl acetate/petroleum ether, and 1-
(1.3g (63χ
)obtain.

N M R((:C1,)δ:  1.Ol、1.05
(both 3H,d、each J−6+1z、>(
:IICIh)、   1.49 −1.I?1l(I
II、m、>CllCl+3ン、  2.12゜2.2
8(both 311.s、NCH))、  2.58
−2.98(2Lm、4−L)。
NMR((:C1,)δ: 1.Ol, 1.05
(both 3H, d, each J-6+1z, >(
:IICIh), 1.49-1. I? 1l (I
II, m,>CllCl+3n, 2.12°2.2
8 (both 311.s, NCH)), 2.58
-2.98 (2Lm, 4-L).

3.54,3.65(both 2!1.s、NC1h
)、  3.68 4.24(2)1.m。
3.54, 3.65 (both 2!1.s, NC1h
), 3.68 4.24 (2) 1. m.

3−1lz)、  4.48  5.24(Ill、m
、l−1f)、7.04(4H,m、八r−H)。
3-1lz), 4.48 5.24(Ill, m
, l-1f), 7.04 (4H, m, 8r-H).

7.22(511,S、C,I+、)。7.22 (511, S, C, I+,).

M S  mHz:  295(M−)。MS mHz: 295 (M-).

実施例13 1− (2−(N−ベンジル−N−メチルアミノ)プロ
ピルイソクロマン1.8gおよびヨウ化メチル7.3g
を無水エーテル30m lに溶かし、このものを10時
間加熱還流する。析出した結晶を濾取し、エーテルで洗
浄し、ベンジル[2−(イソクロマン−1−イル)プロ
パン−2−イル]ジメチルアンモニウムヨーシト1.7
g ([;5χ)を得る。
Example 13 1.8 g of 1-(2-(N-benzyl-N-methylamino)propyl isochroman and 7.3 g of methyl iodide
was dissolved in 30 ml of anhydrous ether and heated under reflux for 10 hours. The precipitated crystals were collected by filtration, washed with ether, and purified with benzyl[2-(isochroman-1-yl)propan-2-yl]dimethylammonium iosito 1.7
g ([;5χ) is obtained.

N M R(CCIa)δ; 1.44−1.91(3
11,m、>CHC)I*)、2.01−2.4111
(2LI++、Cl1zCI+<)、 2.54−3.
OR3Lm、4−11tand >CHCIb)、 3
.21(611,s、N(CIl、)z)、 3.71
−4.21(211,m、3Jlz)、   イ、61
  5.21(31+、m、N(:Ih  and  
l−11)。
NMR(CCIa)δ; 1.44-1.91(3
11, m, >CHC)I*), 2.01-2.4111
(2LI++, Cl1zCI+<), 2.54-3.
OR3Lm, 4-11tand>CHCIb), 3
.. 21(611,s,N(CIl,)z), 3.71
-4.21 (211, m, 3Jlz), i, 61
5.21(31+, m, N(:Ih and
l-11).

3−H2)、 4.48−5.24(Ill、m、[−
11+、7.04(41(、m、Ar4+。
3-H2), 4.48-5.24(Ill, m, [-
11+, 7.04 (41(, m, Ar4+.

6.91−8.11(9)1.m、Ar4)。6.91-8.11(9)1. m, Ar4).

実施例14 (I〕(イソクロマン−1−イルン酢M10gの無水ベ
ンゼン溶液に塩化チオニル!7[を■下後、4時間加熱
還流する。減圧下塩化チオニルを留去し、(イソクロマ
ン−1−イル)アセチルクロリドを油状物として9.5
g(86X) i*る。
Example 14 (I) Add thionyl chloride!7[ to a solution of 10 g of isochroman-1-yl vinegar M in anhydrous benzene and heat under reflux for 4 hours. Thionyl chloride was distilled off under reduced pressure, and (isochroman-1-yl ) Acetyl chloride as oil 9.5
g(86X) i*ru.

I Ru ’、@:tcm−’: 1800 (OH)
I Ru', @:tcm-': 1800 (OH)
.

(2)フェネチルアミン1.4gおよびトリエチルアミ
ン1.1gのfi水エーテル)容ン夜に、(イソクロマ
ン−1−イル)アセチルクロリド2.2gの無水エーテ
ル溶液を滴下する1反応液を室温で30分間撹拌後、酢
酸エチルにて抽出する。酢酸エチル層を5%塩酸、5%
炭酸水素カリウム溶液および水で洗浄し、乾燥後溶媒を
留去する。残渣をエーテルより再結   ′晶し、mp
 89−91℃のN−フェネチル−α−(イソクロマン
−1−イル)アセタミドを2.6g(88χ)得る。
(2) 1.4 g of phenethylamine and 1.1 g of triethylamine in water ether) Add dropwise a solution of 2.2 g of (isochroman-1-yl)acetyl chloride in anhydrous ether. 1. Stir the reaction solution at room temperature for 30 minutes. Afterwards, it is extracted with ethyl acetate. Add ethyl acetate layer to 5% hydrochloric acid, 5%
Wash with potassium hydrogen carbonate solution and water, dry, and then evaporate the solvent. The residue was recrystallized from ether and mp
2.6 g (88.chi.) of N-phenethyl-.alpha.-(isochroman-1-yl)acetamide at 89-91 DEG C. are obtained.

I Rp:::’cm−’: 3270 (Nil)、
  1640 (OH)。
I Rp:::'cm-': 3270 (Nil),
1640 (OH).

N M R((:C1,)δ:2.56−3.0H61
1,n+、Cl1zC[lNIICLCIIz)I3.
31 4.32(4H,m、3−1lz and 4−
11i)、  5.10(11(、t、J=OH2,1
−11)、  6.46 6.71(l11.hr、c
ONH)、  7.13(511,s。
NMR((:C1,)δ:2.56-3.0H61
1,n+,Cl1zC[lNIICLCIIz)I3.
31 4.32 (4H, m, 3-1lz and 4-
11i), 5.10(11(, t, J=OH2,1
-11), 6.46 6.71 (l11.hr, c
ONH), 7.13 (511, s.

C6H3)、7.36(4N、s、Ar−It)。C6H3), 7.36 (4N, s, Ar-It).

MS  ta/z:  295(M’)。MS ta/z: 295 (M').

(3)N−フェネチル−α−(イソクロ°7ンー1−イ
ル)アセタアミド4gの無水エーテル溶液を水素化リチ
ウムアルミニウム2.ICの無水テトラヒドロフラン懸
濶液に滴下し、さらに8時間加熱還流する6反応液に水
を加え、エーテルにて抽出する。
(3) A solution of 4 g of N-phenethyl-α-(isochloro7-1-yl)acetamide in anhydrous ether was added to 2.5 g of lithium aluminum hydride. 6. Water was added to the reaction solution, which was added dropwise to an IC suspension in anhydrous tetrahydrofuran and further heated under reflux for 8 hours, and extracted with ether.

エーテル層を水洗乾燥後、溶媒を留去し、残渣をアルミ
ナカラムクロマトグラフィーに付す0石油エーテル・酢
酸エチルにて溶出し、l−(2−(N−フェネチルアミ
ノ)エチルコイソクロマンを粘稠な油状物として1.1
g(29χ)得る。
After washing and drying the ether layer, the solvent was distilled off and the residue was subjected to alumina column chromatography. It was eluted with 0 petroleum ether and ethyl acetate, and l-(2-(N-phenethylamino)ethylcoisochroman was dissolved in a viscous form. 1.1 as oil
g(29χ) is obtained.

[R’ 、”:x’cs−’ : 329G (Nll
) 。
[R',":x'cs-': 329G (Nll
).

N M R(CC1a) 6 : 1.17(LH,s
、N11)、1.80−2.20(2H,m、cI1g
cl’1JH)+ 2.30 3.22(811,m、
clIJIlcHtcHtPhand 4−Hり、 3
.55−4.23(211,m、3−11z)、 4.
76(lIl、L。
NMR(CC1a) 6 : 1.17(LH,s
, N11), 1.80-2.20 (2H, m, cI1g
cl'1JH) + 2.30 3.22 (811, m,
clIJIlcHtcHtPhand 4-Hri, 3
.. 55-4.23 (211, m, 3-11z), 4.
76 (lIl, L.

J=6112.1−H)、 7.08(411,s、A
r−It)、 7.21(5H,s、C611s)。
J=6112.1-H), 7.08(411,s,A
r-It), 7.21 (5H,s, C611s).

MS Il/z: 28HM”)。MS Il/z: 28HM”).

このものを常法に従って塩酸塩となし、mp168−1
70℃(dec、)の結晶を得る。
This product was converted into hydrochloride according to a conventional method, and mp168-1
Obtain crystals at 70°C (dec).

実施例15〜17 実施例工4の方法と同様な方法で第2表に示す化合物を
いずれも油状物として得た。
Examples 15 to 17 The compounds shown in Table 2 were obtained as oils in the same manner as in Example 4.

手続主甫正書帽発) 昭和59年1り月!6日(From the procedure chief Fu Zhengshu) January 1982! 6th

Claims (10)

【特許請求の範囲】[Claims] (1)一般式 ▲数式、化学式、表等があります▼ (式中、R^1は水素原子、低級アルキル基またはアリ
ール基を、R^2およびR^3は、同一または相異なっ
て、水素原子、アルキル基、アリール基またはアラルキ
ル基を表す)で示されるイソクロマン誘導体。
(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, R^1 is a hydrogen atom, lower alkyl group, or aryl group, R^2 and R^3 are the same or different, and hydrogen an isochroman derivative represented by an atom, an alkyl group, an aryl group, or an aralkyl group.
(2)前記一般式において、R^1がメチル基である特
許請求の範囲第1項記載のイソクロマン誘導体。
(2) The isochroman derivative according to claim 1, wherein in the general formula, R^1 is a methyl group.
(3)前記一般式において、R^2が水素原子または炭
素数1〜5の低級アルキル基であり、R^3が炭素数1
〜7の低級アルキル基、フェニル基、ベンジル基または
フェネチル基である特許請求の範囲第2項記載のイソク
ロマン誘導体。
(3) In the above general formula, R^2 is a hydrogen atom or a lower alkyl group having 1 to 5 carbon atoms, and R^3 is a lower alkyl group having 1 to 5 carbon atoms.
The isochroman derivative according to claim 2, which is a lower alkyl group of ~7, a phenyl group, a benzyl group, or a phenethyl group.
(4)前記一般式において、R^1がフェニル基である
特許請求の範囲第1項記載のイソクロマン誘導体。
(4) The isochroman derivative according to claim 1, wherein in the general formula, R^1 is a phenyl group.
(5)前記一般式において、R^2が水素原子であり、
R^3が炭素数1〜7の低級アルキル基、フェニル基、
ベンジル基またはフェネチル基である特許請求の範囲第
4項記載のイソクロマン誘導体。
(5) In the general formula, R^2 is a hydrogen atom,
R^3 is a lower alkyl group having 1 to 7 carbon atoms, a phenyl group,
The isochroman derivative according to claim 4, which is a benzyl group or a phenethyl group.
(6)前記一般式において、R^1が水素原子である特
許請求の範囲第1項記載のイソクロマン誘導体。
(6) The isochroman derivative according to claim 1, wherein in the general formula, R^1 is a hydrogen atom.
(7)前記一般式において、R^2が水素原子であり、
R^3が炭素数1〜7の低級アルキル基、フェニル基、
ベンジル基またはフェネチル基である特許請求の範囲第
6項記載のイソクロマン誘導体。
(7) In the general formula, R^2 is a hydrogen atom,
R^3 is a lower alkyl group having 1 to 7 carbon atoms, a phenyl group,
The isochroman derivative according to claim 6, which is a benzyl group or a phenethyl group.
(8)一般式 ▲数式、化学式、表等があります▼ (式中、R^1は水素原子、低級アルキル基またはアリ
ール基を表す)で示される化合物と、一般式 R^3−NH_2 (式中、R^3はアルキル基、アリール基またはアラル
キル基を表す)で示されるアミン類を反応させて、一般
式 ▲数式、化学式、表等があります▼ (式中、R^1およびR^3は前記と同じ)で示される
化合物を得、この化合物を還元することを特徴とする一
般式 ▲数式、化学式、表等があります▼ (式中、R^1およびR^3は前記と同じ)で示される
イソクロマン誘導体の製造法。
(8) General formula ▲ Numerical formulas, chemical formulas, tables, etc.▼ (In the formula, R^1 represents a hydrogen atom, a lower alkyl group, or an aryl group) (wherein, R^3 represents an alkyl group, aryl group, or aralkyl group), the general formula ▲ has a mathematical formula, a chemical formula, a table, etc. ▼ (in the formula, R^1 and R^3 is the same as above), and this compound is reduced to a general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^1 and R^3 are the same as above) A method for producing an isochroman derivative shown in
(9)一般式 ▲数式、化学式、表等があります▼ (式中、R^1は水素原子、低級アルキル基およびアリ
ール基を、Xはハロゲン原子を表す)で示される化合物
と、一般式 ▲数式、化学式、表等があります▼ (式中、R^2およびR^3は、同一または相異なって
、水素原子、アルキル基、アリール基またはアラルキル
基を表す)で示されるアミン類を反応させることを特徴
とする一般式 ▲数式、化学式、表等があります▼ (式中、R^1、R^2およびR^3は前記と同じ)で
示されるイソクロマン誘導体の製造法。
(9) General formula▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^1 represents a hydrogen atom, a lower alkyl group, and an aryl group, and X represents a halogen atom) and a compound represented by the general formula▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^2 and R^3 are the same or different and represent a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group) Reacting amines A method for producing an isochroman derivative represented by the general formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (wherein R^1, R^2 and R^3 are the same as above).
(10)一般式 ▲数式、化学式、表等があります▼ (式中、Xはハロゲン原子を表す)で示される化合物と
、一般式 ▲数式、化学式、表等があります▼ (式中、R^2およびR^3は、同一または相異なって
、水素原子、アルキル基、アリール基またはアラルキル
基を表す)で示されるアミン類を反応させて、一般式 ▲数式、化学式、表等があります▼ (式中、R^2およびR^3は前記と同じ)で示される
化合物を得、この化合物を還元することを特徴とする一
般式 ▲数式、化学式、表等があります▼ (式中、R^2およびR^3は前記と同じ)で示される
イソクロマン誘導体の製造法。
(10) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, X represents a halogen atom) Compounds represented by the general formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^ 2 and R^3 are the same or different and represent a hydrogen atom, an alkyl group, an aryl group, or an aralkyl group) to form the general formula ▲ mathematical formula, chemical formula, table, etc. In the formula, R^2 and R^3 are the same as above) A general formula is obtained, which is characterized by reducing this compound. There are mathematical formulas, chemical formulas, tables, etc. 2 and R^3 are the same as above).
JP20539984A 1984-09-29 1984-09-29 Isochroman derivative and its preparation Pending JPS6183180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20539984A JPS6183180A (en) 1984-09-29 1984-09-29 Isochroman derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20539984A JPS6183180A (en) 1984-09-29 1984-09-29 Isochroman derivative and its preparation

Publications (1)

Publication Number Publication Date
JPS6183180A true JPS6183180A (en) 1986-04-26

Family

ID=16506185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20539984A Pending JPS6183180A (en) 1984-09-29 1984-09-29 Isochroman derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS6183180A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5860611A (en) * 1995-02-21 1999-01-19 Tdk Corporation Tape cassette and recording and reproducing apparatus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5860611A (en) * 1995-02-21 1999-01-19 Tdk Corporation Tape cassette and recording and reproducing apparatus

Similar Documents

Publication Publication Date Title
US4940793A (en) Pharmacologically active piperazino derivatives
US4297282A (en) Resolution of mercaptopropionic acids
US4824953A (en) Multi-step process for producing 5-hydroxy-N-(6-oxo-piperidyl-methyl)-2-(2,2,2-trifluoro-ethoxy)-benzamide and derivatives
JPS5921862B2 (en) Esterification method
US4808725A (en) Process for the preparation of the (-)-antipode of (E)-1-cyclohexyl-4, 4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ene
JPH0610191B2 (en) Process for producing pyrrolidone derivative
JPS6183180A (en) Isochroman derivative and its preparation
US2510784A (en) Bis (tertiaryaminoalkyl) arylacetonitriles and the corresponding acids and esters
US4555573A (en) Certain 6-benzamidomethyl-2(1H)-pyridone derivatives
HU220971B1 (en) Process for producing 0-(3-amino-2-hidroxy-propyl)-hidroxim acid halogenids
US4411836A (en) Racemization of an α-methyl-β-acylthiopropionic acid
JP2678758B2 (en) Novel propane derivative
KR100275978B1 (en) Process for the preparation of n-methyl-n(4-(4-phenyl-4acetylaminopiperidine-1-yl)-2-(3,4-dichlorophenyl)butyl)benzamide
US4238622A (en) D,L-2-Amino-4-(2-aminoethoxy)-trans-but-3-enoic acid derivatives
US4656285A (en) Compound 2-acetamidomethyl-6-methoxy-pyridine
US4533732A (en) 3-Propionylsalicylic acid derivatives and process for the preparation of the same
KR20020015031A (en) Synthesis of 3-amino-3-aryl propanoates
KR100305152B1 (en) Manufacturing method of C-substituted diethylene triamine
IL142760A (en) Method for producing 4-Ä(2&#39;,5&#39;-diamino-6&#39;- halopyrimidine-4&#39; -yl) aminoÜ-cyclopent -2- enyl-methanols
SU1250170A3 (en) Method of producing pyrbuterol dichlorhydrate
JPS61178947A (en) Manufacture of arylalkyl ketone
JPS5910354B2 (en) Method for producing N-leucyl agmatine compound
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
JPS6160673A (en) Preparation of guanidinothiazole derivative
JPS6319504B2 (en)